Article Versions Notes

Ohyama S, Morioka I, Fukushima S, Yamana K, Nishida K, Iwatani S, Fujioka K, Matsumoto H, Imanishi T, Nakamachi Y, et al. Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection. International Journal of Molecular Sciences. 2019; 20(6):1388. https://doi.org/10.3390/ijms20061388

Ohyama, Shohei, Ichiro Morioka, Sachiyo Fukushima, Keiji Yamana, Kosuke Nishida, Sota Iwatani, Kazumichi Fujioka, Hisayuki Matsumoto, Takamitsu Imanishi, Yuji Nakamachi, and et al. 2019. "Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection" International Journal of Molecular Sciences 20, no. 6: 1388. https://doi.org/10.3390/ijms20061388

Ohyama, S., Morioka, I., Fukushima, S., Yamana, K., Nishida, K., Iwatani, S., Fujioka, K., Matsumoto, H., Imanishi, T., Nakamachi, Y., Deguchi, M., Tanimura, K., Iijima, K., & Yamada, H. (2019). Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection. International Journal of Molecular Sciences, 20(6), 1388. https://doi.org/10.3390/ijms20061388